US 9676746
Crystalline forms of C21H22Cl2N4O2
granted A61KA61K31/4439A61K45/06
Quick answer
US patent 9676746 (Crystalline forms of C21H22Cl2N4O2) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 82
- CPC classes
- A61K, A61K31/4439, A61K45/06, A61P, A61P35/00